These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 31537188)
21. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke. Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274 [TBL] [Abstract][Full Text] [Related]
22. High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia. Stahrenberg R; Niehaus CF; Edelmann F; Mende M; Wohlfahrt J; Wasser K; Seegers J; Hasenfuß G; Gröschel K; Wachter R J Neurol Neurosurg Psychiatry; 2013 May; 84(5):479-87. PubMed ID: 23355808 [TBL] [Abstract][Full Text] [Related]
23. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke. Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401 [TBL] [Abstract][Full Text] [Related]
24. Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment. Højsgaard Chow H; Petersen ER; Olsson A; Hejgaard Laursen J; Bredahl Hansen M; Oturai AB; Soelberg Sørensen P; Bach Søndergaard H; Sellebjerg F Mult Scler Relat Disord; 2024 Aug; 88():105701. PubMed ID: 38889559 [TBL] [Abstract][Full Text] [Related]
25. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP; Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638 [TBL] [Abstract][Full Text] [Related]
27. Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study. Barbieri A; Giuliani E; Carone C; Pederzoli F; Mascheroni G; Greco G; Stucchi C; Genedani S Minerva Anestesiol; 2013 Jul; 79(7):750-7. PubMed ID: 23511364 [TBL] [Abstract][Full Text] [Related]
28. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke. Yip HK; Sun CK; Chang LT; Chen MC; Liou CW Circ J; 2006 Apr; 70(4):447-52. PubMed ID: 16565563 [TBL] [Abstract][Full Text] [Related]
29. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526 [TBL] [Abstract][Full Text] [Related]
30. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death]. Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992 [TBL] [Abstract][Full Text] [Related]
34. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. Katan M; Fluri F; Schuetz P; Morgenthaler NG; Zweifel C; Bingisser R; Kappos L; Steck A; Engelter ST; Müller B; Christ-Crain M J Am Coll Cardiol; 2010 Sep; 56(13):1045-53. PubMed ID: 20846604 [TBL] [Abstract][Full Text] [Related]
35. Plasma heart-type fatty acid binding protein level in acute ischemic stroke: comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome. Park SY; Kim MH; Kim OJ; Ahn HJ; Song JY; Jeong JY; Oh SH Clin Neurol Neurosurg; 2013 Apr; 115(4):405-10. PubMed ID: 22766253 [TBL] [Abstract][Full Text] [Related]
36. Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke. Doehner W; von Haehling S; Suhr J; Ebner N; Schuster A; Nagel E; Melms A; Wurster T; Stellos K; Gawaz M; Bigalke B J Am Coll Cardiol; 2012 Jul; 60(4):346-54. PubMed ID: 22813614 [TBL] [Abstract][Full Text] [Related]
37. The Association of Serum Neurofilament Light Chain and Acute Ischaemic Stroke Is Influenced by Effective Revascularization. Zhou FY; Chen DW; Li HY; Zhu C; Shen YY; Peng ZY; Li L; Bu XL; Zeng GH; Zhang M; Wang YJ; Jin WS Dis Markers; 2022; 2022():5236080. PubMed ID: 35557872 [TBL] [Abstract][Full Text] [Related]
38. Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study. Greisenegger S; Segal HC; Burgess AI; Poole DL; Mehta Z; Rothwell PM Stroke; 2015 Mar; 46(3):659-66. PubMed ID: 25649803 [TBL] [Abstract][Full Text] [Related]
39. RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke. England TJ; Hedstrom A; O'Sullivan S; Donnelly R; Barrett DA; Sarmad S; Sprigg N; Bath PM Stroke; 2017 May; 48(5):1412-1415. PubMed ID: 28265014 [TBL] [Abstract][Full Text] [Related]